TD SYNNEX insider to sell 17,500 shares via Morgan Stanley
Rhea-AI Filing Summary
TD SYNNEX Corp (SNX) Form 144 reports a proposed sale of 17,500 common shares through Morgan Stanley Smith Barney LLC on 10/09/2025, with an aggregate market value of $2,738,730.75. The filer states these shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists 81,437,855 shares outstanding, and shows recent disposals by the Polk Family Trust of 3,000 shares on each of 08/04/2025, 09/04/2025, and 10/06/2025 generating gross proceeds of $426,529.20, $445,486.80, and $477,258.30 respectively. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Positive
- Exercise-funded sale of 17,500 shares was paid in cash, indicating liquidity without non-cash consideration
- Brokered execution via Morgan Stanley suggests an orderly sale process to minimize market disruption
Negative
- Insider sale of 17,500 shares on 10/09/2025 increases available shares in the market
- Recent dispositions total 9,000 shares across three sales in the past three months, indicating ongoing selling activity
Insights
Insider exercised options and plans a single-block sale for liquidity.
The filing shows the insider exercised stock options on 10/09/2025 and intends to sell 17,500 shares through Morgan Stanley, a common execution route for option-related liquidity. The $2.74M notional size is small relative to the 81.4M shares outstanding, so the transaction is unlikely to materially change ownership stakes.
The seller also disclosed three small prior sales totaling 9,000 shares across 08/04/2025–10/06/2025, indicating a pattern of periodic dispositions rather than a single large exit. Watch the actual trade execution on 10/09/2025 for executed size and any subsequent filings that would confirm completion.
Trade size is notable in dollar terms but limited versus float, so market impact should be modest.
A block sale of $2.74M executed through a major broker typically executes with limited price disruption for a large-cap issuer. Given the company's 81.4M shares outstanding, this represents a small fraction of supply and is unlikely to move the market materially on its own.
Key near-term items to monitor include the actual executed proceeds reported after 10/09/2025 and whether similar option-exercise sales continue, which could modestly increase share supply over successive reporting periods.
AI-generated analysis. How Rhea-AI works. Not financial advice.